240 related articles for article (PubMed ID: 6269038)
1. Oral contraceptives and postmolar trophoblastic disease.
Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
[TBL] [Abstract][Full Text] [Related]
2. Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen.
Eddy GL; Schlaerth JB; Nalick RH; Gaddis O; Nakamura RM; Morrow CP
Obstet Gynecol; 1983 Dec; 62(6):736-40. PubMed ID: 6633999
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study).
Curry SL; Schlaerth JB; Kohorn EI; Boyce JB; Gore H; Twiggs LB; Blessing JA
Am J Obstet Gynecol; 1989 Apr; 160(4):805-9; discussion 809-11. PubMed ID: 2540654
[TBL] [Abstract][Full Text] [Related]
5. The role of contraception in the development of postmolar gestational trophoblastic tumor.
Deicas RE; Miller DS; Rademaker AW; Lurain JR
Obstet Gynecol; 1991 Aug; 78(2):221-6. PubMed ID: 1648697
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
7. Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy.
Ho Yuen B; Burch P
Am J Obstet Gynecol; 1983 Jan; 145(2):214-7. PubMed ID: 6849356
[TBL] [Abstract][Full Text] [Related]
8. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
[TBL] [Abstract][Full Text] [Related]
9. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
10. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and post-molar trophoblastic tumours.
Berkowitz RS; Marean AR; Goldstein DP; Bernstein MR
Lancet; 1980 Oct; 2(8197):752. PubMed ID: 6106866
[TBL] [Abstract][Full Text] [Related]
12. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
[TBL] [Abstract][Full Text] [Related]
13. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
15. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
16. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
[TBL] [Abstract][Full Text] [Related]
17. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
18. Development of postmolar trophoblastic disease after partial molar pregnancy.
Goto S; Yamada A; Ishizuka T; Tomoda Y
Gynecol Oncol; 1993 Feb; 48(2):165-70. PubMed ID: 8428686
[TBL] [Abstract][Full Text] [Related]
19. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole.
Stone M; Dent J; Kardana A; Bagshawe KD
Br J Obstet Gynaecol; 1976 Dec; 83(12):913-6. PubMed ID: 188441
[TBL] [Abstract][Full Text] [Related]
20. Guidelines following hydatidiform mole: a reappraisal.
Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
